Back to Freepaper Session
enVista toric: insights from early experience
Session Title: Toric IOL Outcomes
Session Date/Time: Monday 07/10/2013 | 16:30-18:30
Paper Time: 17:33
Venue: Auditorium (First Floor)
First Author: : O.Moraru ROMANIA
Co Author(s): : I. Iliescu
To present the clinical outcomes in a group of patients operated for cataract with implantion of a new hydrophobic toric intraocular lens (IOL). The rotational stability of the lens was also followed.
Oculus Eye Clinic Bucharest Romania
This prospective cohort consisted of 18 eyes with medium or advanced cataract and a moderate corneal astigmatism less than 2.0D. After Coaxial Microincision Cataract Surgery (C-MICS), an enVista® toric (Model MX60T) intraocular lens was implanted in the capsular bag. Three toric cylinder powers were evaluated: 1.25D, 2.00D and 2.75 D (IOL plane). The postoperative distance uncorrected visual acuity (UCVA), best corrected visual acuity (BCVA), objective and subjective (manifest) refraction, spectacle independence and IOL axis alignment were measured at 1 month. A further 3 months follow-up will also be evaluated.
The study includes 18 eyes with 1 Month follow-up with preoperative corneal astigmatism from 0.75D to 1.75D. 100% of eyes achieved a postoperative UCVA of 20/40 or better and 87% of 20/30 or better. The postoperative BCVA was 20/25 or better in 93.3% of eyes. The postoperative subjective refractive cylinder was 0.5 D or less in 80% of eyes which shows a high postoperative spectacle independence for distance vision. IOL axis rotation was 5° or less in all eyes with 80% of the eyes with 2 degrees or less of IOL rotation. No complications occurred.
Our results show that the implantation of the enVista® toric IOL is a safe and effective procedure to correct moderate corneal astigmatism in cataract patients.
... travel has been funded, fully or partially, by a company producing, developing or supplying the product or procedure presented